Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308737 · ClinicalTrials.gov registry record · Phase 3
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
A Phase 3 study, sponsored by Mannkind Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,053
- Enrollment target
NCT00308737: Completed Phase 3 study, sponsored by Mannkind Corporation.
NCT00308737 is a Phase 3 study that has completed, run by Mannkind Corporation. The registered enrollment target is 2,053 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (166% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00308737, a Phase 3 study, has completed, sponsored by Mannkind Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,053 participants
- Enrollment target
Study Summary
Pulmonary Safety in Diabetics with T/I
Primary Outcome
Change from Baseline to End of Study in FEV1 by MMRM
Interventions
- DRUG Usual Care
- DRUG Technosphere® Insulin Inhalation Powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,053 participants |
| Start Date | 2005-06 |
| Est. Completion | 2008-10 |
| Phase | Phase 3 |
What the finished NCT00308737 record still lists
NCT00308737 is an interventional study that assigns participants to a tested intervention. Its 2,053 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (166% higher).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT00308737 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00308737 about?
NCT00308737 is a clinical study titled "Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes". Pulmonary Safety in Diabetics with T/I
What is the current status of trial NCT00308737?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,053 participants. The study started on 2005-06. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00308737?
The interventions under investigation include: Usual Care (DRUG), Technosphere® Insulin Inhalation Powder (DRUG).
Who is sponsoring clinical trial NCT00308737?
This trial is sponsored by Mannkind Corporation, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00308737's enrollment target sits among peer trials
2,053 99th of 2000 higher than 1,902 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05050084 · 2,050 participants · Phase 3
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
- NCT05688982 · 2,049 participants · NA
MOLAR: Mapping Oral Health and Local Area Resources
- NCT04871542 · 2,062 participants
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
- NCT06521944 · 2,062 participants
RSV Vaccine Pregnancy Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia